Creatinine Test Market is estimated to be US$ 3892.86 million by 2030 with a CAGR of 16.4% during the forecast period

 

Creatinine Test Market accounted for US$ 845.1 million in 2020 and is estimated to be US$ 3892.86 million by 2030 and is anticipated to register a CAGR of 16.4%. The amount of creatinine in the blood is determined via a creatinine blood test. This test determines how well your kidneys are functioning. Urine testing can also be used to measure creatinine. Creatinine Test Market learns about Creatinine Test, This creatinine test is used to track and determine the progression of acute renal damage and chronic kidney disease (CKD). First urine test, creatinine clearance test, and serum test are the three different kinds of creatinine tests.

The report  Global  Creatinine Test Market By Test Type ( Blood test and Urine test ) By Instruments ( Clinical Analyzer, Creatinine Test Strips and Cartridge) By Indication (  Kidney Disease, Kidney Failure and Urinary Tract Obstruction) , By End User(Hospitals and Clinics ,Diagnostic Center ,and Research Institutes)  and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029’’

Key Highlights:

·         In March 2022, The CE-marked Nova Max Pro creatinine/eGFR metre system was introduced by Nova Biomedical in the EU market. Through early kidney disease diagnosis and renal function testing outside of the hospital, Nova Max Pro is intended to enhance kidney care. From a 1.2 mL capillary fingerstick blood sample, the metre and creatinine biosensor assess blood creatinine and estimate glomerular filtration rate in 30 seconds. The Nova StatSensor Creatinine technology serves as the foundation for the measurement system.

Analyst View:

The market for creatinine tests is anticipated to expand as a result of the growing applications for these tests. For instance, increased creatinine levels have been connected to prostate cancer in male adults, whereas they have been linked to bacteremia in babies. Due to diabetes and high blood pressure, the blood's level of creatinine has also increased. As a result, the market for creatinine tests is expanding due to the rising prevalence of diabetes. Additionally, several medications, like cimetidine (Bactrim), might unnaturally raise creatinine levels.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/94

Key Market Insights from the report:

Global Creatinine Test Market accounted for US$ 845.1 million in 2020 and is estimated to be US$ 3892.86 million by 2030 and is anticipated to register a CAGR of 16.4%. The Global Creatinine Test Market is segmented based on test type, instrument, end-user and region.

·         Based on test type Creatinine Test Market is Segmented into Blood test and Urine test

·         Based on instrument ,Creatinine Test Market is bifurcated  into Clinical Analyzer, Creatinine Test Strips and Cartridge

·         Based on End-User is target market is segmented into Hospitals and Clinics ,Diagnostic Center and Research Institutes

·         By Region, Global Creatinine Test Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Creatinine Test Market

The prominent key players operating the creatinine test market, include Beckman Coulter, Quest Diagnostics, Bayer, Merck, Abbott, Sonic Healthcare, Laboratory Corporation of America Holdings, Genoptix, Health scope, Charles River, OPKO Health, Inc., and Labco.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused on developing novel,
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, Intravenous, and
Read more